Physician

Tushar Ranchod, MD

According to 2025 Medicare claims, Tushar Ranchod, MD (NPI: 1316003304) practices ophthalmology in the Oakland-Fremont-Berkeley, CA market, with the plurality of this provider's patient population coming from Alameda, CA. This provider's primary affiliated billing organization is BAY AREA RETINA ASSOCIATES (NPI: 1174557805; TIN: 94-3064464) and primary practice location at 94538-1518.

Ranchod's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 962 traditional Medicare patients, billed 58,443 HCPCS/CPT codes, and received $2,604,235 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 212 prescription claims across 84 beneficiaries totaling $10,433 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 14 records totaling $844. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,579,678 to $2,604,235. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $16,410 and ending at $10,433. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.7M2015 Medicare payment: $1,579,678 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,510,257 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,758,596 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,843,004 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,649,172 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,681,261 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,030,908 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,315,008 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,734,632 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,604,235 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156076,813$1,579,678
20166366,684$1,510,257
20176887,568$1,758,596
20186447,979$1,843,004
20197447,824$1,649,172
20206497,065$1,681,261
20217068,805$2,030,908
202282915,335$2,315,008
202392250,529$2,734,632
202496258,443$2,604,235

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$24K2015 Drug cost: $16,410 (USD; Tot_Drug_Cst)2016 Drug cost: $23,834 (USD; Tot_Drug_Cst)2017 Drug cost: $15,144 (USD; Tot_Drug_Cst)2018 Drug cost: $14,802 (USD; Tot_Drug_Cst)2019 Drug cost: $19,366 (USD; Tot_Drug_Cst)2020 Drug cost: $11,014 (USD; Tot_Drug_Cst)2021 Drug cost: $13,717 (USD; Tot_Drug_Cst)2022 Drug cost: $8,205 (USD; Tot_Drug_Cst)2023 Drug cost: $20,349 (USD; Tot_Drug_Cst)2024 Drug cost: $10,433 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201567190$16,410
201655147$23,834
201760134$15,144
201852120$14,802
201945114$19,366
202041102$11,014
202153158$13,717
202251131$8,205
202376176$20,349
202484212$10,433

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2861,216$112
92014Established patient complete exam of visual system654952$110
92012Established patient problem focused exam of visual system221404$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more204360$78
92134Imaging of retina8722,464$37

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate713,532$3,327
DifluprednateDifluprednate32997$2,804
MoxifloxacinMoxifloxacin Hcl36625$611
LatanoprostLatanoprost17625$322

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$844ANI Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tushar Ranchod, MD?

Tedicare shows public-source Medicare data for Tushar Ranchod, MD (NPI 1316003304), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tushar Ranchod, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tushar Ranchod, MD?

Tushar Ranchod, MD is linked to BAY AREA RETINA ASSOCIATES (billing NPI 1174557805) in the available physician profile data.

Does Tushar Ranchod, MD have Open Payments data?

Tushar Ranchod, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.